Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Dongdaemoon-Ku, Seoul, Republic of Korea.
Neurochem Res. 2010 Nov;35(11):1725-32. doi: 10.1007/s11064-010-0235-y. Epub 2010 Aug 1.
Previously, we reported the cognitive enhancing effects of oroxylin A in unimpaired mice and its memory ameliorating activity in various memory impaired mice. To elucidate the mechanism mediating the cognitive effects of oroxylin A, this study examined the consequences of oroxylin A administration on neurogenesis in the hippocampal dentate gyrus using immunostaining for 5-bromo-2-deoxyuridine (BrdU) incorporation. In addition, we determined whether the new cells adopted a neuronal or glial fate by examining the co-localization of BrdU staining with neuronal or glial markers. Administration of oroxylin A in a dose-dependent and time-dependent manner increased the number of BrdU-incorporating cells. Moreover, the percentage of BrdU-incorporating cells co-localized with neuronal markers, neuronal nuclei, was significantly increased by the oroxylin A administration. These results suggest that the increased neurogenesis induced by the administration of oroxylin A could be, at least in part, associated with its positive effects on cognitive processing.
此前,我们报道了白杨素 A 在未受损小鼠中的认知增强作用及其在各种记忆损伤小鼠中的改善记忆活性。为了阐明白杨素 A 认知作用的机制,本研究使用 BrdU(5-溴-2-脱氧尿苷)掺入免疫染色检测白杨素 A 给药对海马齿状回神经发生的影响。此外,我们通过检查 BrdU 染色与神经元或神经胶质标记物的共定位,确定新细胞是否采用神经元或神经胶质命运。白杨素 A 以剂量依赖和时间依赖的方式给药,增加 BrdU 掺入细胞的数量。此外,白杨素 A 给药后 BrdU 掺入细胞与神经元标记物神经元核的共定位百分比显著增加。这些结果表明,白杨素 A 给药诱导的神经发生增加至少部分与它对认知加工的积极影响有关。